Peninsula Capital (European private equity)
Peninsula Capital describes a flexible European private-equity approach centered on companies with strong fundamentals and earning power. Its stated mandate spans healthcare and pharmaceuticals, industrial and logistics, business and financial services, and consumer, retail and leisure.
What stands out about Peninsula Capital (European private equity)
Peninsula Capital publicly states that it focuses on European private-equity investments, particularly in Spain, Italy and France, with a €60 million to €120 million per-single-transaction sweet spot. It can invest in majority or minority stakes, primary or secondary transactions, and additional M&A or capital-expenditure projects.[1][2][3][7][8][17]
What does Peninsula Capital (European private equity) invest in?
Peninsula Capital describes itself as a European private-equity investor backing companies with strong fundamentals and earning power while working alongside managers and other stakeholders to create long-term value.
Peninsula Capital Advisors LLP is described as a UK-based financial advisory company advising Peninsula Capital Investments and its affiliates on the sourcing, structuring and execution of private-equity deals in Europe. The official homepage reports 20 investments executed since 2017, approximately €3 billion of capital raised since inception, 16 investment-team members and five European offices and branches.[1][2]
Peninsula describes a flexible, long-term approach using tailor-made transaction structures and working alongside entrepreneurs and managers. It invests in equity and equity-linked securities through both primary capital-issuance transactions and secondary liquidity transactions.
The firm states that it has equal appetite for majority and minority shareholdings. It also states that C-level executives remain in control of day-to-day operations, that it limits recourse to leverage and that it remains open to investing additional capital for attractive M&A and capital-expenditure projects.[3]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Peninsula Capital (European private equity)?
An owner evaluating Peninsula may wish to clarify which legal entity and fund would make the investment, whether the proposed transaction would be majority, minority, primary, secondary or a combination, and what governance and reserved-matter rights would apply.
Other points to confirm include the specific fund’s remaining commitments, applicable financial thresholds, leverage use and preserved debt headroom, availability of follow-on capital, management roles and rollover expectations, ownership horizon or exit approach, and the fees, expenses, exclusivity, break-fee, indemnity and seller-liability provisions for the proposed transaction.[2][3][7][8]
What are the current fund's remaining commitments and investment-period deadlines
Is the proposed transaction expected to be majority, minority, primary, secondary or a combination
What companies does Peninsula Capital (European private equity) target?
Peninsula describes its target companies as businesses with strong fundamentals and earning power. Its stated transaction sweet spot ranges from €60 million to €120 million per single transaction, either upfront or cumulatively across the investment lifecycle, including further capital for M&A, growth projects or secondary stake building.
Peninsula states that it can deploy significantly larger amounts, up to €1 billion, through co-investment agreements. The About page does not publish current AUM, fund-by-fund commitments or fund sizes.[1][3]
Peninsula’s stated investment mandate covers healthcare and pharmaceuticals; industrial and logistics; business and financial services; and consumer, retail and leisure.[1]
Peninsula states that its investment team is based in Madrid, Milan and Paris and that investments focus on Spain, Italy and France because of the local teams’ knowledge and networks. The Peninsula Group also states that it is active across various geographies through local presence.[2][3]
Peninsula states that it can provide additional capital for M&A and capital-expenditure projects. Its ISEM Group portfolio page states that, during Peninsula’s holding period, ISEM acquired Industrial Pack, Sacchettificio Toscano, Bartoli and Egisa.
These disclosures establish follow-on capital and add-on acquisition examples without establishing a standardized platform-versus-add-on policy.[3][5]
The official portfolio names Aernnova, Isola dei Tesori, ISEM Group, MC2 Saint Barth, Mattioli, Zadig & Voltaire, Galenicum, WM Clinics, Prima Industrie, Neural Mentalia, Salto Systems, HLC Distribution, ClubFunding and Veralab.
Specific portfolio disclosures state that Peninsula acquired a majority stake in ISEM Group alongside management, acquired a minority stake in Veralab, acquired a significant minority stake in MC2 Saint Barth alongside its founders and acquired a majority stake in Prima Industrie through a co-owned vehicle with Alpha Private Equity and management.[4][5][6][9][12]
In 2026, Peninsula sold the majority of ISEM Group to Multiply Group / 2pointzero and re-invested in the transaction with a significant minority stake.
On January 8, 2024, Peninsula announced entry into Veralab’s share capital through a 30 percent stake in Reforme Srl, the owner of the Veralab brand. On November 8, 2022, Peninsula Capital and the Percassi Group announced a binding agreement to acquire a 40% stake in MC2 Saint Barth.
Other public transaction announcements include ISEM Group’s October 7, 2022 announcement of an agreement to acquire Industrial Pack into an entity controlled by Peninsula; Peninsula’s August 18, 2022 announcement of the signing of the acquisition of the majority of voting rights in Prima Industrie together with Alpha; and the October 17, 2022 announcement that Percassi had agreed to purchase Peninsula’s KIKO stake, with Peninsula fully divesting its shares.[5][7][8][10][11][13]
What is not clear from Peninsula Capital (European private equity)'s public investment criteria?
The About page publishes approximately €3 billion of capital raised since inception and an investment-size sweet spot, but does not publish current AUM, fund-by-fund commitments or fund sizes.
The About page describes a flexible approach in terms of time horizon and patient capital but does not state a numeric investment holding-period range or standard exit timetable. The official news archive does not publish transaction values or consideration terms for the listed announcements.
The Veralab transaction page does not state the purchase price, financing structure or Peninsula fund identity. The MC2 Saint Barth transaction page likewise does not state the purchase price, financing structure or Peninsula fund identity.[3][7][8][17]
Questions to ask when evaluating Peninsula Capital (European private equity) as a buyer or investment partner
Which Peninsula legal entity and fund would make the investment?
What are the current fund's remaining commitments and investment-period deadlines?
Is the proposed transaction expected to be majority, minority, primary, secondary or a combination?
What EBITDA, enterprise-value, revenue, margin or growth thresholds apply to the specific fund?
What governance, reserved-matter and board rights would Peninsula require?
How much leverage would be used and what debt headroom would be preserved?
What follow-on capital is available for acquisitions or capital expenditure?
What is the expected ownership horizon or exit approach for this investment?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Investment strategy
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
- Structure / regulatory context
- Structure / regulatory context
- Public disclosure information
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.
